A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator-Reference-Cited by-同舟云学术

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator

Published:2018-02 Issue:2 Volume:6 Page:96-104
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Armstrong Paul W.,Roessig Lothar,Patel Mahesh J.,Anstrom Kevin J.,Butler Javed,Voors Adriaan A.,Lam Carolyn S.P.,Ponikowski Piotr,Temple Tracy,Pieske Burkert,Ezekowitz Justin,Hernandez Adrian F.,Koglin Joerg,O'Connor Christopher M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Yancy;J Am Coll Cardiol,2013

2. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity;Brutsaert;Physiol Rev,2003

3. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice;Buys;Cardiovasc Res,2008

4. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction;van Heerebeek;Circulation,2012

5. Soluble guanylate cyclase: a potential therapeutic target for heart failure;Gheorghiade;Heart Fail Rev,2013

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examination of the Suitability of Vericiguat in Non-Heart Failure with Preserved Ejection Fraction Patients with Improved Ejection Fraction;Journal of Clinical Medicine;2024-09-05

2. Comparing Analytical Methods for Composite Endpoints in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (VICTORIA) Trial;Journal of Cardiac Failure;2024-09

3. The Role of Titin Phosphorylation in Changes in Myocardial Stiffness in Cardiomyopathies;Российский физиологический журнал им И М Сеченова;2024-09-01

4. Biomarker profiles associated with reverse ventricular remodelling in patients with heart failure and a reduced ejection fraction: Insights from the echocardiographic substudy of the VICTORIA trial;European Journal of Heart Failure;2024-07-30

5. A Review of Contemporary and Future Pharmacotherapy for Chronic Heart Failure in Children;Children;2024-07-16